Zynex

OverviewSuggest Edit

Zynex is a company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include an electrical nerve stimulation device, and electromyography triggered an electrical stimulation device, as well as a device for the treatment of female urinary incontinence.
TypePublic
Founded1996
HQEnglewood, USMap
Websitezynex.com
Employee Ratings3.6More
View Jobs (12)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2018)182(+67%)
Job Openings12
Revenue (FY, 2018)$31.9 M(+37%)
Share Price (Dec 2019)$8.7 (-3%)

Key People/Management at Zynex

Thomas Sandgaard

Thomas Sandgaard

Chairman of the Board, President and Chief Executive Officer
Dan Moorhead

Dan Moorhead

CFO
Christopher Brown

Christopher Brown

VP of Sales & Marketing
Martin Sandgaard

Martin Sandgaard

Production Manager
Anna Lucsok

Anna Lucsok

Billing Manager
Show more

Zynex Office Locations

Zynex has an office in Englewood
Englewood, US (HQ)
9555 Maroon Cir
Show all (1)

Zynex Financials and Metrics

Zynex Revenue

Embed Graph
View revenue for all periods
Zynex's revenue was reported to be $31.92 m in FY, 2018
USD

Revenue (Q3, 2019)

11.8m

Gross profit (Q3, 2019)

9.6m

Gross profit margin (Q3, 2019), %

80.9%

Net income (Q3, 2019)

2.0m

EBIT (Q3, 2019)

2.5m

Market capitalization (12-Dec-2019)

283.2m

Closing stock price (12-Dec-2019)

8.7

Cash (30-Sept-2019)

11.9m

EV

275.1m
Zynex's current market capitalization is $283.2 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

34.1m39.7m21.7m11.1m11.6m13.3m23.4m31.9m

Cost of goods sold

7.4m8.8m8.1m4.2m4.9m3.5m4.8m6.0m

Gross profit

26.8m30.9m13.5m6.9m6.7m9.8m18.6m25.9m

Gross profit Margin, %

78%78%62%62%58%74%79%81%
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

8.4m9.4m8.9m10.0m10.1m7.7m5.5m5.2m3.2m1.3m4.4m3.2m3.1m2.7m3.5m3.3m3.6m3.4m5.0m6.8m6.9m7.6m8.1m9.2m10.3m11.8m

Cost of goods sold

1.7m1.9m1.8m1.8m2.2m2.2m1.9m1.5m997.0k903.0k1.2m1.1m1.1m726.0k983.0k941.0k880.0k923.0k1.0m1.3m1.2m1.3m1.6m1.8m1.9m2.3m

Gross profit

6.7m7.5m7.1m8.2m7.9m5.5m3.6m3.6m2.2m446.0k3.2m2.1m2.0m1.9m2.5m2.3m2.7m2.5m4.0m5.5m5.6m6.2m6.5m7.4m8.3m9.6m

Gross profit Margin, %

79%79%80%82%78%71%66%70%69%33%73%65%65%73%72%71%76%73%80%80%82%82%80%81%81%81%
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

789.0k823.0k323.0k63.0k8.0k247.0k5.6m10.1m

Accounts Receivable

11.0m12.2m7.0m3.2m2.4m3.0m2.2m2.8m

Prepaid Expenses

293.0k243.0k346.0k250.0k27.0k40.0k198.0k570.0k

Inventories

4.6m6.2m5.0m1.9m305.0k107.0k423.0k837.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

783.0k761.0k742.0k623.0k843.0k681.0k445.0k468.0k189.0k311.0k319.0k348.0k87.0k41.0k24.0k29.0k91.0k462.0k140.0k2.6m4.4m6.3m8.1m9.4m10.1m11.9m

Accounts Receivable

9.5m10.8m11.6m12.1m12.3m11.2m9.8m8.8m6.3m5.0m4.5m2.9m2.7m2.8m3.2m3.2m4.0m2.9m2.5m2.4m2.7m2.9m2.9m3.1m3.5m4.3m

Prepaid Expenses

136.0k146.0k304.0k202.0k210.0k256.0k194.0k178.0k244.0k173.0k37.0k191.0k130.0k40.0k20.0k123.0k28.0k148.0k125.0k211.0k615.0k579.0k364.0k738.0k833.0k321.0k

Inventories

3.8m4.3m5.6m6.6m6.7m6.3m5.8m6.1m5.0m2.6m2.5m1.6m1.4m1.1m173.0k164.0k96.0k128.0k178.0k358.0k710.0k518.0k796.0k968.0k1.3m2.1m
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

1.6m1.6m(7.3m)(6.2m)(2.9m)69.0k7.4m9.6m

Depreciation and Amortization

806.0k864.0k839.0k660.0k424.0k435.0k286.0k448.0k

Inventories

(1.0m)(2.1m)(279.0k)726.0k1.6m198.0k(316.0k)(414.0k)

Accounts Payable

876.0k(132.0k)686.0k(199.0k)(67.0k)402.0k(1.2m)(515.0k)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

374.0k965.0k320.0k793.0k1.2m(304.0k)(2.0m)(2.8m)(1.4m)(7.0m)(6.7m)

Depreciation and Amortization

389.0k594.0k213.0k432.0k647.0k213.0k417.0k647.0k156.0k309.0k469.0k

Inventories

(93.0k)(791.0k)(995.0k)(2.1m)(2.3m)(181.0k)123.0k(265.0k)(23.0k)400.0k186.0k

Accounts Payable

145.0k848.0k335.0k516.0k264.0k(382.0k)51.0k232.0k162.0k258.0k2.0k
show all
USDY, 2019

EV/EBIT

110.3 x

EV/CFO

65.4 x

Financial Leverage

1.5 x
Show all financial metrics

Zynex Online and Social Media Presence

Zynex's Trends

Embed Graph

Zynex News and Updates

December 02, 2019

Zynex to Present at the Piper Jaffray 31st Annual Healthcare Conference

ENGLEWOOD, Colo., Dec. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today...
October 02, 2019

Zynex Announces 95% Order Growth

ENGLEWOOD, Colo., Oct. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today...
June 12, 2019

Zynex to Present at Raymond James Life Sciences and MedTech Conference

ENGLEWOOD, Colo., June 12, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today...
February 07, 2019

Zynex Announces Uplisting to The Nasdaq Capital Market

ENGLEWOOD, Colo., Feb. 7, 2019 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, is...
November 06, 2018

Zynex Announces 2018 Third Quarter Earnings and Special Dividend

ENGLEWOOD, Colo., Nov. 6, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today...
November 02, 2018

Zynex Schedules 2018 Third Quarter Earnings Release and Webcast

ENGLEWOOD, Colo., Nov. 2, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced...
Show more

Zynex Blogs

November 14, 2019

Zynex Ranked 18th in Revenue Growth Among Medical Device Companies

October 29, 2019

Zynex Announces 2019 Third Quarter Financial Results

- Revenue increased 45% year over year to $11.8 million
October 17, 2019

Zynex Schedules 2019 Third Quarter Earnings

July 31, 2019

Zynex Announces 2019 Second Quarter Earnings

- Revenue increased 36% year over year to $10.3 million
July 23, 2019

Zynex Recognized as The Fastest Growing Public Company in Colorado based on Net Income

July 22, 2019

Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer

Show more

 Zynex Frequently Asked Questions

  • When was Zynex founded?

    Zynex was founded in 1996.

  • Who are Zynex key executives?

    Zynex's key executives are Thomas Sandgaard, Dan Moorhead and Christopher Brown.

  • How many employees does Zynex have?

    Zynex has 182 employees.

  • What is Zynex revenue?

    Latest Zynex annual revenue is $31.9 m.

  • What is Zynex revenue per employee?

    Latest Zynex revenue per employee is $175.4 k.

  • Who are Zynex competitors?

    Competitors of Zynex include Non-Invasive Monitoring Systems, Crawford Healthcare and Atlantic Therapeutics.

  • Where is Zynex headquarters?

    Zynex headquarters is located at 9555 Maroon Cir, Englewood.

  • Where are Zynex offices?

    Zynex has an office in Englewood.

  • How many offices does Zynex have?

    Zynex has 1 office.